Serial bipolar androgen therapy (sBAT) using cyclic supraphysiologic testosterone (STP) to treat metastatic castration-resistant prostate cancer (mCRPC).
作者信息
Isaacs John T, Brennen W Nathaniel, Denmeade Samuel R
机构信息
Department of Oncology, The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins and The Brady Urologic Institute, Baltimore, MD, USA.
Department of Urology, The Johns Hopkins University School of Medicine, Baltimore, MD, USA.
出版信息
Ann Transl Med. 2019 Dec;7(Suppl 8):S311. doi: 10.21037/atm.2019.10.32.
Abstract
摘要
相似文献
1
Serial bipolar androgen therapy (sBAT) using cyclic supraphysiologic testosterone (STP) to treat metastatic castration-resistant prostate cancer (mCRPC).
Ann Transl Med. 2019 Dec;7(Suppl 8):S311. doi: 10.21037/atm.2019.10.32.
2
Clinical response in metastatic castration-resistant prostate cancer (mCRPC) cases treated with supra-physiological doses of testosterone: Bipolar androgen therapy.
Clin Case Rep. 2022 Feb 10;10(2):e05433. doi: 10.1002/ccr3.5433. eCollection 2022 Feb.
3
Anticancer Activity and Tolerance of Treatments Received Beyond Progression in Men Treated Upfront with Androgen Deprivation Therapy With or Without Docetaxel for Metastatic Castration-naïve Prostate Cancer in the GETUG-AFU 15 Phase 3 Trial.
Eur Urol. 2018 May;73(5):696-703. doi: 10.1016/j.eururo.2017.09.022. Epub 2017 Oct 23.
4
Role of free testosterone levels in patients with metastatic castration-resistant prostate cancer receiving second-line therapy.
Oncol Lett. 2017 Jan;13(1):22-28. doi: 10.3892/ol.2016.5392. Epub 2016 Nov 17.
5
Anemia is associated with poor outcomes of metastatic castration-resistant prostate cancer, a systematic review and meta-analysis.
Am J Transl Res. 2018 Dec 15;10(12):3877-3886. eCollection 2018.
6
Variations in circulating sex steroid levels in metastatic prostate cancer patients with combined androgen blockade: observation and implication.
Andrology. 2013 May;1(3):512-6. doi: 10.1111/j.2047-2927.2013.00078.x. Epub 2013 Mar 28.
7
Update on Systemic Prostate Cancer Therapies: Management of Metastatic Castration-resistant Prostate Cancer in the Era of Precision Oncology.
Eur Urol. 2019 Jan;75(1):88-99. doi: 10.1016/j.eururo.2018.03.028. Epub 2018 Apr 16.
8
Bipolar Androgen Therapy for Men With Androgen Ablation Naïve Prostate Cancer: Results From the Phase II BATMAN Study.
Prostate. 2016 Sep;76(13):1218-26. doi: 10.1002/pros.23209. Epub 2016 Jun 24.
9
[Testosterone in the management of metastatic prostate cancer].
Urologe A. 2015 Nov;54(11):1578-83. doi: 10.1007/s00120-015-3813-4.
10
Abiraterone acetate to treat metastatic castration-resistant prostate cancer in combination with prednisone.
Drugs Today (Barc). 2019 Jan;55(1):5-15. doi: 10.1358/dot.2019.55.1.2914339.
引用本文的文献
1
The oncogenic lncRNA MIR503HG suppresses cellular senescence counteracting supraphysiological androgen treatment in prostate cancer.
J Exp Clin Cancer Res. 2024 Dec 16;43(1):321. doi: 10.1186/s13046-024-03233-2.
2
Functional circuits of LYL1 controlled by supraphysiological androgen in prostate cancer cells to regulate cell senescence.
Cell Commun Signal. 2024 Dec 12;22(1):590. doi: 10.1186/s12964-024-01970-7.
3
The Novel Direct AR Target Gene Annexin A2 Mediates Androgen-Induced Cellular Senescence in Prostate Cancer Cells.
Biochem Genet. 2024 Nov 19. doi: 10.1007/s10528-024-10953-9.
4
The clock gene BHLHE40 and atypical CCNG2 control androgen-induced cellular senescence as a novel tumor suppressive pathway in prostate cancer.
J Exp Clin Cancer Res. 2024 Jun 20;43(1):174. doi: 10.1186/s13046-024-03097-6.
5
The future of patient-derived xenografts in prostate cancer research.
Nat Rev Urol. 2023 Jun;20(6):371-384. doi: 10.1038/s41585-022-00706-x. Epub 2023 Jan 17.
6
Androgen Flare after LHRH Initiation Is the Side Effect That Makes Most of the Beneficial Effect When It Coincides with Radiation Therapy for Prostate Cancer.
Cancers (Basel). 2022 Apr 13;14(8):1959. doi: 10.3390/cancers14081959.
7
The androgen receptor-lncRNASAT1-AKT-p15 axis mediates androgen-induced cellular senescence in prostate cancer cells.
Oncogene. 2022 Feb;41(7):943-959. doi: 10.1038/s41388-021-02060-5. Epub 2021 Oct 19.
8
Antithetic hTERT Regulation by Androgens in Prostate Cancer Cells: hTERT Inhibition Is Mediated by the ING1 and ING2 Tumor Suppressors.
Cancers (Basel). 2021 Aug 10;13(16):4025. doi: 10.3390/cancers13164025.
9
Phenotypic characterization of two novel cell line models of castration-resistant prostate cancer.
Prostate. 2021 Nov;81(15):1159-1171. doi: 10.1002/pros.24210. Epub 2021 Aug 16.
本文引用的文献
1
Supraphysiological androgens suppress prostate cancer growth through androgen receptor-mediated DNA damage.
J Clin Invest. 2019 Jul 16;129(10):4245-4260. doi: 10.1172/JCI127613.
2
Durable Response of Enzalutamide-resistant Prostate Cancer to Supraphysiological Testosterone Is Associated with a Multifaceted Growth Suppression and Impaired DNA Damage Response Transcriptomic Program in Patient-derived Xenografts.
Eur Urol. 2020 Feb;77(2):144-155. doi: 10.1016/j.eururo.2019.05.042. Epub 2019 Jun 19.
3
Bipolar androgen therapy in men with metastatic castration-resistant prostate cancer after progression on enzalutamide: an open-label, phase 2, multicohort study.
Lancet Oncol. 2018 Jan;19(1):76-86. doi: 10.1016/S1470-2045(17)30906-3. Epub 2017 Dec 14.
4
Androgen Receptor Tumor Suppressor Function Is Mediated by Recruitment of Retinoblastoma Protein.
Cell Rep. 2016 Oct 18;17(4):966-976. doi: 10.1016/j.celrep.2016.09.064.
5
Effect of bipolar androgen therapy for asymptomatic men with castration-resistant prostate cancer: results from a pilot clinical study.
Sci Transl Med. 2015 Jan 7;7(269):269ra2. doi: 10.1126/scitranslmed.3010563.
6
Conversion of androgen receptor signaling from a growth suppressor in normal prostate epithelial cells to an oncogene in prostate cancer cells involves a gain of function in c-Myc regulation.
Int J Biol Sci. 2014 Jun 10;10(6):627-42. doi: 10.7150/ijbs.8756. eCollection 2014.
7
Androgen receptor (AR) suppresses normal human prostate epithelial cell proliferation via AR/β-catenin/TCF-4 complex inhibition of c-MYC transcription.
Prostate. 2014 Aug;74(11):1118-31. doi: 10.1002/pros.22828. Epub 2014 Jun 9.
8
Adaptive auto-regulation of androgen receptor provides a paradigm shifting rationale for bipolar androgen therapy (BAT) for castrate resistant human prostate cancer.
Prostate. 2012 Oct 1;72(14):1491-505. doi: 10.1002/pros.22504. Epub 2012 Mar 6.
9
Androgen receptor gene expression in prostate cancer is directly suppressed by the androgen receptor through recruitment of lysine-specific demethylase 1.
Cancer Cell. 2011 Oct 18;20(4):457-71. doi: 10.1016/j.ccr.2011.09.001.
10
Transcription-induced DNA double strand breaks: both oncogenic force and potential therapeutic target?
Clin Cancer Res. 2011 Jun 15;17(12):3858-64. doi: 10.1158/1078-0432.CCR-10-2044. Epub 2011 Mar 8.
Zotero 插件